id	sid	eid	entity	type
ajlm-1720	1	1	leanne swart department	ORG
ajlm-1720	1	2	charlotte maxeke	PERSON
ajlm-1720	1	3	johannesburg academic hospital	ORG
ajlm-1720	1	4	national health laboratory service	ORG
ajlm-1720	1	5	johannesburg	GPE
ajlm-1720	1	6	south africa	GPE
ajlm-1720	1	7	university of the witwatersrand	ORG
ajlm-1720	1	8	johannesburg	GPE
ajlm-1720	1	9	south africa	GPE
ajlm-1720	1	10	melanie	PERSON
ajlm-1720	1	11	pretorius department	ORG
ajlm-1720	1	12	charlotte maxeke	PERSON
ajlm-1720	1	13	johannesburg academic hospital	ORG
ajlm-1720	1	14	national health laboratory service	ORG
ajlm-1720	1	15	johannesburg	GPE
ajlm-1720	1	16	south africa	GPE
ajlm-1720	1	17	university of the witwatersrand	ORG
ajlm-1720	1	18	johannesburg	GPE
ajlm-1720	1	19	south africa	GPE
ajlm-1720	1	20	denise lawrie department	PERSON
ajlm-1720	1	21	charlotte maxeke	PERSON
ajlm-1720	1	22	johannesburg academic hospital	ORG
ajlm-1720	1	23	national health laboratory service	ORG
ajlm-1720	1	24	johannesburg	GPE
ajlm-1720	1	25	south africa	GPE
ajlm-1720	1	26	university of the witwatersrand	ORG
ajlm-1720	1	27	johannesburg	GPE
ajlm-1720	1	28	south africa	GPE
ajlm-1720	1	29	deborah k. glencross	PERSON
ajlm-1720	1	30	charlotte maxeke	PERSON
ajlm-1720	1	31	johannesburg academic hospital	ORG
ajlm-1720	1	32	national health laboratory service	ORG
ajlm-1720	1	33	johannesburg	GPE
ajlm-1720	1	34	south africa	GPE
ajlm-1720	1	35	university of the witwatersrand	ORG
ajlm-1720	1	36	johannesburg	GPE
ajlm-1720	1	37	south africa	GPE
ajlm-1720	1	38	swart l	ORG
ajlm-1720	1	39	lawrie	PERSON
ajlm-1720	1	40	south africa	GPE
ajlm-1720	2	1	afr j	PERSON
ajlm-1720	3	1	2022;11(1	CARDINAL
ajlm-1720	3	2	south africa	GPE
ajlm-1720	3	3	leanne swart	PERSON
ajlm-1720	3	4	melanie pretorius	PERSON
ajlm-1720	3	5	denise lawrie	PERSON
ajlm-1720	3	6	deborah k. glencross	PERSON
ajlm-1720	3	7	31	CARDINAL
ajlm-1720	3	8	aug. 2021	DATE
ajlm-1720	3	9	28	CARDINAL
ajlm-1720	3	10	29 nov.	DATE
ajlm-1720	4	1	2022	CARDINAL
ajlm-1720	4	2	2022	CARDINAL
ajlm-1720	9	1	beckman coulter	PERSON
ajlm-1720	9	2	duraclone	PERSON
ajlm-1720	10	1	second	ORDINAL
ajlm-1720	10	2	charlotte	GPE
ajlm-1720	10	3	johannesburg academic hospital	ORG
ajlm-1720	10	4	johannesburg	GPE
ajlm-1720	10	5	south africa	GPE
ajlm-1720	10	6	april to august 2020	DATE
ajlm-1720	11	1	second	ORDINAL
ajlm-1720	12	1	17	CARDINAL
ajlm-1720	14	1	100%	PERCENT
ajlm-1720	14	2	second	ORDINAL
ajlm-1720	14	3	cd56	PERSON
ajlm-1720	14	4	cd81	ORG
ajlm-1720	14	5	ror-1	GPE
ajlm-1720	14	6	cd43	ORG
ajlm-1720	15	1	second	ORDINAL
ajlm-1720	15	2	second	ORDINAL
ajlm-1720	15	3	cd5+ b-lpd	ORG
ajlm-1720	15	4	non-cd5+	GPE
ajlm-1720	15	5	cd5	PERSON
ajlm-1720	16	1	cd58	ORG
ajlm-1720	19	1	counterparts2	NORP
ajlm-1720	19	2	populations3	PERSON
ajlm-1720	21	1	bc	ORG
ajlm-1720	21	2	cd5+	ORG
ajlm-1720	24	1	bc	ORG
ajlm-1720	24	2	10c16	CARDINAL
ajlm-1720	24	3	beckman coulter	PERSON
ajlm-1720	24	4	miami	GPE
ajlm-1720	24	5	florida	GPE
ajlm-1720	24	6	united states	GPE
ajlm-1720	25	1	10c	CARDINAL
ajlm-1720	26	1	bc	ORG
ajlm-1720	26	2	10c	CARDINAL
ajlm-1720	26	3	cd58	ORG
ajlm-1720	27	1	10c	CARDINAL
ajlm-1720	27	2	cd23	PRODUCT
ajlm-1720	27	3	cd43	ORG
ajlm-1720	27	4	cd81	ORG
ajlm-1720	27	5	rawstron et al.17,18	PERSON
ajlm-1720	27	6	10c	CARDINAL
ajlm-1720	28	1	2–4	CARDINAL
ajlm-1720	28	2	second	ORDINAL
ajlm-1720	28	3	cd23	PRODUCT
ajlm-1720	28	4	cd56	PERSON
ajlm-1720	28	5	cd200	GPE
ajlm-1720	30	1	400	CARDINAL
ajlm-1720	30	2	second	ORDINAL
ajlm-1720	31	1	second	ORDINAL
ajlm-1720	32	1	beckman coulter	PERSON
ajlm-1720	32	2	mumbai	GPE
ajlm-1720	32	3	india	GPE
ajlm-1720	32	4	second	ORDINAL
ajlm-1720	33	1	two	CARDINAL
ajlm-1720	34	1	first	ORDINAL
ajlm-1720	34	2	2–4	CARDINAL
ajlm-1720	34	3	cd10	GPE
ajlm-1720	34	4	cd23	PRODUCT
ajlm-1720	34	5	cd22	ORG
ajlm-1720	34	6	cd19	PRODUCT
ajlm-1720	34	7	cd38	PRODUCT
ajlm-1720	34	8	cd56	GPE
ajlm-1720	34	9	cd200	GPE
ajlm-1720	35	1	secondly	ORDINAL
ajlm-1720	35	2	2–4	CARDINAL
ajlm-1720	35	3	cd43	ORG
ajlm-1720	35	4	cd81	ORG
ajlm-1720	35	5	cd38	PRODUCT
ajlm-1720	35	6	cd27	PRODUCT
ajlm-1720	35	7	cd81	ORG
ajlm-1720	35	8	cd56	PERSON
ajlm-1720	36	1	cd58	ORG
ajlm-1720	36	2	first	ORDINAL
ajlm-1720	36	3	10c	CARDINAL
ajlm-1720	38	1	beckman coulter duraclone	ORG
ajlm-1720	38	2	second	ORDINAL
ajlm-1720	38	3	second	ORDINAL
ajlm-1720	39	1	second	ORDINAL
ajlm-1720	40	1	april 2020 to	DATE
ajlm-1720	40	2	august 2020	DATE
ajlm-1720	40	3	the national health laboratory service	ORG
ajlm-1720	40	4	charlotte	GPE
ajlm-1720	40	5	johannesburg	GPE
ajlm-1720	40	6	johannesburg	GPE
ajlm-1720	40	7	south africa	GPE
ajlm-1720	41	1	charlotte	GPE
ajlm-1720	41	2	johannesburg academic hospital	ORG
ajlm-1720	41	3	south africa	GPE
ajlm-1720	43	1	the united kingdom	GPE
ajlm-1720	43	2	uk neqas	ORG
ajlm-1720	43	3	sheffield	GPE
ajlm-1720	43	4	united kingdom	GPE
ajlm-1720	43	5	1	CARDINAL
ajlm-1720	43	6	2	CARDINAL
ajlm-1720	43	7	scheme.21	ORG
ajlm-1720	43	8	charlotte	GPE
ajlm-1720	43	9	johannesburg	GPE
ajlm-1720	43	10	two	CARDINAL
ajlm-1720	44	1	firstly	ORDINAL
ajlm-1720	44	2	first	ORDINAL
ajlm-1720	44	3	bc	ORG
ajlm-1720	44	4	10	CARDINAL
ajlm-1720	44	5	beckman coulter	PERSON
ajlm-1720	44	6	miami	GPE
ajlm-1720	44	7	florida	GPE
ajlm-1720	44	8	united states	GPE
ajlm-1720	45	1	first	ORDINAL
ajlm-1720	45	2	cd38	PRODUCT
ajlm-1720	46	1	10c	CARDINAL
ajlm-1720	46	2	second	ORDINAL
ajlm-1720	46	3	first	ORDINAL
ajlm-1720	47	1	second	ORDINAL
ajlm-1720	47	2	cd23	PRODUCT
ajlm-1720	47	3	cd38	PRODUCT
ajlm-1720	48	1	second	ORDINAL
ajlm-1720	48	2	cd23	PRODUCT
ajlm-1720	48	3	cd20	PRODUCT
ajlm-1720	48	4	cd43	ORG
ajlm-1720	48	5	81	CARDINAL
ajlm-1720	48	6	cd23	PRODUCT
ajlm-1720	48	7	cll	ORG
ajlm-1720	48	8	cd5	PERSON
ajlm-1720	48	9	non-cd5	ORG
ajlm-1720	48	10	10c	CARDINAL
ajlm-1720	48	11	second	ORDINAL
ajlm-1720	48	12	1	CARDINAL
ajlm-1720	48	13	at least 1 ml	CARDINAL
ajlm-1720	49	1	at least 20	CARDINAL
ajlm-1720	49	2	60	CARDINAL
ajlm-1720	51	1	57	CARDINAL
ajlm-1720	51	2	second	ORDINAL
ajlm-1720	51	3	13	CARDINAL
ajlm-1720	52	1	duraclone alb testing	PERSON
ajlm-1720	52	2	20	CARDINAL
ajlm-1720	53	1	eleven	CARDINAL
ajlm-1720	53	2	nine	CARDINAL
ajlm-1720	54	1	one	CARDINAL
ajlm-1720	54	2	nine	CARDINAL
ajlm-1720	55	1	twenty	CARDINAL
ajlm-1720	55	2	10c	CARDINAL
ajlm-1720	55	3	second	ORDINAL
ajlm-1720	56	1	12	CARDINAL
ajlm-1720	56	2	seven	CARDINAL
ajlm-1720	57	1	facscalibur	NORP
ajlm-1720	57	2	second	ORDINAL
ajlm-1720	57	3	only 17	CARDINAL
ajlm-1720	57	4	10	CARDINAL
ajlm-1720	57	5	second	ORDINAL
ajlm-1720	58	1	1	CARDINAL
ajlm-1720	58	2	april 2020 to	DATE
ajlm-1720	58	3	johannesburg	GPE
ajlm-1720	58	4	south africa	GPE
ajlm-1720	59	1	bc	ORG
ajlm-1720	59	2	miami	GPE
ajlm-1720	59	3	florida	GPE
ajlm-1720	59	4	united states	GPE
ajlm-1720	59	5	facscalibur	NORP
ajlm-1720	59	6	becton dickinson biosciences	PERSON
ajlm-1720	59	7	san jose	GPE
ajlm-1720	59	8	california	GPE
ajlm-1720	59	9	united states	GPE
ajlm-1720	61	1	daily	DATE
ajlm-1720	62	1	bc	ORG
ajlm-1720	62	2	lismeehan	GPE
ajlm-1720	62	3	ireland	GPE
ajlm-1720	63	1	bc	ORG
ajlm-1720	63	2	lismeehan	GPE
ajlm-1720	63	3	ireland	GPE
ajlm-1720	64	1	10c	CARDINAL
ajlm-1720	64	2	bc	ORG
ajlm-1720	65	1	10c	CARDINAL
ajlm-1720	65	2	duraclone multicolour	ORG
ajlm-1720	66	1	facscalibur	NORP
ajlm-1720	66	2	second	ORDINAL
ajlm-1720	66	3	2–4	CARDINAL
ajlm-1720	66	4	san jose	GPE
ajlm-1720	66	5	california	GPE
ajlm-1720	66	6	united states	GPE
ajlm-1720	67	1	daily	DATE
ajlm-1720	67	2	3	CARDINAL
ajlm-1720	67	3	apc	ORG
ajlm-1720	67	4	becton dickinson biosciences	PERSON
ajlm-1720	67	5	san jose	GPE
ajlm-1720	67	6	california	GPE
ajlm-1720	67	7	united states	GPE
ajlm-1720	68	1	bc	ORG
ajlm-1720	68	2	brea	GPE
ajlm-1720	68	3	california	GPE
ajlm-1720	68	4	united states	GPE
ajlm-1720	68	5	four	CARDINAL
ajlm-1720	68	6	cd14	ORG
ajlm-1720	68	7	cd13 pe	PERSON
ajlm-1720	68	8	cd45	ORG
ajlm-1720	68	9	becton dickinson biosciences	PERSON
ajlm-1720	68	10	san jose	GPE
ajlm-1720	68	11	california	GPE
ajlm-1720	68	12	united states	GPE
ajlm-1720	69	1	two or more 0.5 ml	QUANTITY
ajlm-1720	69	2	14.5 ml	QUANTITY
ajlm-1720	69	3	8.99%	PERCENT
ajlm-1720	69	4	0.84%	PERCENT
ajlm-1720	69	5	0.0372%	PERCENT
ajlm-1720	69	6	merck	ORG
ajlm-1720	69	7	darmstadt	GPE
ajlm-1720	69	8	germany	GPE
ajlm-1720	69	9	15 ml	QUANTITY
ajlm-1720	69	10	15 min	TIME
ajlm-1720	70	1	3000	CARDINAL
ajlm-1720	70	2	3 min	TIME
ajlm-1720	70	3	four	CARDINAL
ajlm-1720	70	4	14 ml	QUANTITY
ajlm-1720	70	5	7.3 ± 2	MONEY
ajlm-1720	70	6	oxoid ltd	ORG
ajlm-1720	70	7	basingstoke	ORG
ajlm-1720	70	8	united kingdom	GPE
ajlm-1720	70	9	0.09%	PERCENT
ajlm-1720	70	10	merck	ORG
ajlm-1720	70	11	darmstadt	GPE
ajlm-1720	70	12	germany	GPE
ajlm-1720	70	13	0.2%	PERCENT
ajlm-1720	70	14	nuaille	ORG
ajlm-1720	70	15	france	GPE
ajlm-1720	71	1	0.5 ml	QUANTITY
ajlm-1720	72	1	≤ 10 000	QUANTITY
ajlm-1720	73	1	100	CARDINAL
ajlm-1720	73	2	approximately 106	CARDINAL
ajlm-1720	73	3	10c	CARDINAL
ajlm-1720	73	4	1	CARDINAL
ajlm-1720	74	1	10c	CARDINAL
ajlm-1720	74	2	100	CARDINAL
ajlm-1720	74	3	duraclone alb	PERSON
ajlm-1720	74	4	1	CARDINAL
ajlm-1720	75	1	2	CARDINAL
ajlm-1720	76	1	duraclone	ORG
ajlm-1720	77	1	two	CARDINAL
ajlm-1720	77	2	cd22	PRODUCT
ajlm-1720	77	3	apc	ORG
ajlm-1720	77	4	bc	ORG
ajlm-1720	77	5	miami	GPE
ajlm-1720	77	6	florida	GPE
ajlm-1720	77	7	united states	GPE
ajlm-1720	77	8	alb	ORG
ajlm-1720	77	9	apc	ORG
ajlm-1720	77	10	2	CARDINAL
ajlm-1720	77	11	duraclone	ORG
ajlm-1720	77	12	alb panel	ORG
ajlm-1720	77	13	cd22	ORG
ajlm-1720	78	1	bc	ORG
ajlm-1720	78	2	miami	GPE
ajlm-1720	78	3	florida	GPE
ajlm-1720	78	4	united states	GPE
ajlm-1720	79	1	20 °	QUANTITY
ajlm-1720	79	2	22 °	QUANTITY
ajlm-1720	79	3	15 min	DATE
ajlm-1720	80	1	0.5 ml	QUANTITY
ajlm-1720	80	2	2	CARDINAL
ajlm-1720	80	3	charlotte	GPE
ajlm-1720	80	4	johannesburg	GPE
ajlm-1720	80	5	johannesburg	GPE
ajlm-1720	80	6	south africa	GPE
ajlm-1720	80	7	april 2020 to august 2020	DATE
ajlm-1720	82	1	facscalibur	NORP
ajlm-1720	82	2	5000	CARDINAL
ajlm-1720	83	1	becton dickinson biosciences	PERSON
ajlm-1720	83	2	san jose	GPE
ajlm-1720	83	3	california	GPE
ajlm-1720	83	4	united states	GPE
ajlm-1720	83	5	facscalibur	NORP
ajlm-1720	83	6	cd45	ORG
ajlm-1720	84	1	at least 50 000	CARDINAL
ajlm-1720	85	1	1.1	CARDINAL
ajlm-1720	85	2	bc	ORG
ajlm-1720	85	3	miami	GPE
ajlm-1720	85	4	florida	GPE
ajlm-1720	85	5	united states	GPE
ajlm-1720	86	1	m1 and m2	PRODUCT
ajlm-1720	86	2	specifications.23	PERSON
ajlm-1720	86	3	cd45	ORG
ajlm-1720	87	1	m1 and m2 panels.9,16	PRODUCT
ajlm-1720	87	2	cd45	ORG
ajlm-1720	87	3	1	CARDINAL
ajlm-1720	87	4	2	CARDINAL
ajlm-1720	88	1	1	CARDINAL
ajlm-1720	88	2	cd81	ORG
ajlm-1720	88	3	charlotte	GPE
ajlm-1720	88	4	johannesburg	GPE
ajlm-1720	88	5	johannesburg	GPE
ajlm-1720	88	6	south africa	GPE
ajlm-1720	88	7	april 2020 to august 2020	DATE
ajlm-1720	89	1	cd81	PERSON
ajlm-1720	90	1	cd81	ORG
ajlm-1720	90	2	cll gated on cd19+|cd5+	ORG
ajlm-1720	90	3	cd81	ORG
ajlm-1720	90	4	20%	PERCENT
ajlm-1720	90	5	cd81	ORG
ajlm-1720	90	6	cd45+| cd19+.	ORG
ajlm-1720	90	7	cd19	PRODUCT
ajlm-1720	90	8	cd45	ORG
ajlm-1720	90	9	cd5	PERSON
ajlm-1720	91	1	2	CARDINAL
ajlm-1720	91	2	charlotte	GPE
ajlm-1720	91	3	johannesburg	GPE
ajlm-1720	91	4	johannesburg	GPE
ajlm-1720	91	5	south africa	GPE
ajlm-1720	91	6	april 2020 to august 2020	DATE
ajlm-1720	92	1	cd45	LAW
ajlm-1720	92	2	cd45	ORG
ajlm-1720	93	1	cd38	PRODUCT
ajlm-1720	93	2	cd117	ORG
ajlm-1720	93	3	cd81	ORG
ajlm-1720	93	4	cd27	PRODUCT
ajlm-1720	94	1	second	ORDINAL
ajlm-1720	95	1	the world health organization	ORG
ajlm-1720	95	2	2016	CARDINAL
ajlm-1720	95	3	cd27	PRODUCT
ajlm-1720	95	4	cd43	ORG
ajlm-1720	95	5	cd56	PERSON
ajlm-1720	95	6	cd58	ORG
ajlm-1720	95	7	cd81	ORG
ajlm-1720	95	8	10c	CARDINAL
ajlm-1720	95	9	second	ORDINAL
ajlm-1720	96	1	cd19/cd10/cd34	ORG
ajlm-1720	96	2	cd20	PRODUCT
ajlm-1720	96	3	cd38	PRODUCT
ajlm-1720	96	4	cd58	ORG
ajlm-1720	97	1	cd19/cd5	ORG
ajlm-1720	97	2	cd19/cd20	PRODUCT
ajlm-1720	97	3	cd43	ORG
ajlm-1720	97	4	cd81	PERSON
ajlm-1720	98	1	cd38	PRODUCT
ajlm-1720	98	2	cd81	ORG
ajlm-1720	98	3	cd27	PRODUCT
ajlm-1720	98	4	cd19	ORG
ajlm-1720	98	5	cd56	PERSON
ajlm-1720	98	6	cd45	LAW
ajlm-1720	99	1	microsoft	ORG
ajlm-1720	99	2	redmond	GPE
ajlm-1720	99	3	washington	GPE
ajlm-1720	99	4	united states	GPE
ajlm-1720	100	1	2–4	CARDINAL
ajlm-1720	100	2	2	CARDINAL
ajlm-1720	102	1	10	CARDINAL
ajlm-1720	103	1	cll	ORG
ajlm-1720	103	2	cd23	NORP
ajlm-1720	103	3	second	ORDINAL
ajlm-1720	103	4	cll	ORG
ajlm-1720	103	5	cd43	ORG
ajlm-1720	104	1	second	ORDINAL
ajlm-1720	105	1	second	ORDINAL
ajlm-1720	106	1	first	ORDINAL
ajlm-1720	106	2	second	ORDINAL
ajlm-1720	107	1	twenty	CARDINAL
ajlm-1720	107	2	alb	ORG
ajlm-1720	108	1	duraclone	ORG
ajlm-1720	108	2	100%	PERCENT
ajlm-1720	108	3	10c	CARDINAL
ajlm-1720	108	4	3	CARDINAL
ajlm-1720	109	1	100%	PERCENT
ajlm-1720	110	1	cd58	ORG
ajlm-1720	110	2	cd58	PRODUCT
ajlm-1720	111	1	cd22 apc	PRODUCT
ajlm-1720	111	2	two	CARDINAL
ajlm-1720	111	3	two	CARDINAL
ajlm-1720	111	4	alb	ORG
ajlm-1720	111	5	3	CARDINAL
ajlm-1720	112	1	3	CARDINAL
ajlm-1720	112	2	charlotte	GPE
ajlm-1720	112	3	johannesburg	GPE
ajlm-1720	112	4	johannesburg	GPE
ajlm-1720	112	5	south africa	GPE
ajlm-1720	112	6	april 2020 to august 2020	DATE
ajlm-1720	113	1	clb panel	ORG
ajlm-1720	113	2	cd19	PRODUCT
ajlm-1720	113	3	cd5	PERSON
ajlm-1720	113	4	cd20	PRODUCT
ajlm-1720	113	5	cd81	PERSON
ajlm-1720	113	6	cd43	ORG
ajlm-1720	114	1	twenty	CARDINAL
ajlm-1720	115	1	100%	PERCENT
ajlm-1720	116	1	cll	ORG
ajlm-1720	116	2	cd81	ORG
ajlm-1720	116	3	cd20	PRODUCT
ajlm-1720	116	4	4	CARDINAL
ajlm-1720	117	1	15	CARDINAL
ajlm-1720	117	2	93.75%	PERCENT
ajlm-1720	118	1	cll	ORG
ajlm-1720	118	2	cll	ORG
ajlm-1720	118	3	cd43	ORG
ajlm-1720	120	1	three	CARDINAL
ajlm-1720	120	2	15%	PERCENT
ajlm-1720	120	3	second	ORDINAL
ajlm-1720	121	1	2	CARDINAL
ajlm-1720	121	2	20%	PERCENT
ajlm-1720	121	3	cd81	ORG
ajlm-1720	121	4	1	CARDINAL
ajlm-1720	122	1	4	CARDINAL
ajlm-1720	122	2	charlotte	GPE
ajlm-1720	122	3	johannesburg	GPE
ajlm-1720	122	4	johannesburg	GPE
ajlm-1720	122	5	south africa	GPE
ajlm-1720	122	6	april 2020 to august 2020	DATE
ajlm-1720	123	1	seventeen	CARDINAL
ajlm-1720	124	1	cd38	PRODUCT
ajlm-1720	124	2	cd19	PRODUCT
ajlm-1720	124	3	cd27	PRODUCT
ajlm-1720	124	4	cd45	FAC
ajlm-1720	124	5	cd56	PERSON
ajlm-1720	124	6	cd200	LOC
ajlm-1720	125	1	5	CARDINAL
ajlm-1720	125	2	100%	PERCENT
ajlm-1720	125	3	100%	PERCENT
ajlm-1720	126	1	cd27	ORG
ajlm-1720	126	2	cd81	ORG
ajlm-1720	126	3	cd81	ORG
ajlm-1720	126	4	cd27	PRODUCT
ajlm-1720	126	5	2	CARDINAL
ajlm-1720	127	1	2	CARDINAL
ajlm-1720	127	2	cd117	ORG
ajlm-1720	127	3	10c	CARDINAL
ajlm-1720	129	1	5	CARDINAL
ajlm-1720	129	2	charlotte	GPE
ajlm-1720	129	3	johannesburg	GPE
ajlm-1720	129	4	johannesburg	GPE
ajlm-1720	129	5	south africa	GPE
ajlm-1720	129	6	april 2020 to august 2020	DATE
ajlm-1720	130	1	10c	CARDINAL
ajlm-1720	130	2	m1 and m2	PRODUCT
ajlm-1720	130	3	ls11	PRODUCT
ajlm-1720	130	4	facscalibur	NORP
ajlm-1720	131	1	400	CARDINAL
ajlm-1720	132	1	2–4	CARDINAL
ajlm-1720	133	1	10c	CARDINAL
ajlm-1720	133	2	laboratory16	ORG
ajlm-1720	136	1	reliable16	ORG
ajlm-1720	138	1	cd23	PRODUCT
ajlm-1720	138	2	cd43	ORG
ajlm-1720	138	3	cd58	ORG
ajlm-1720	138	4	cd81	ORG
ajlm-1720	139	1	cd38	FAC
ajlm-1720	139	2	cd56	PERSON
ajlm-1720	139	3	cd45	ORG
ajlm-1720	140	1	cd56	PERSON
ajlm-1720	140	2	cd38	PRODUCT
ajlm-1720	141	1	three	CARDINAL
ajlm-1720	142	1	cd10	PERSON
ajlm-1720	142	2	cd19	PRODUCT
ajlm-1720	142	3	cd38	PRODUCT
ajlm-1720	142	4	cd20	PRODUCT
ajlm-1720	142	5	cd45	FAC
ajlm-1720	142	6	alb	ORG
ajlm-1720	142	7	10c	CARDINAL
ajlm-1720	143	1	cd38	ORG
ajlm-1720	143	2	cd19	PRODUCT
ajlm-1720	143	3	cd20	PRODUCT
ajlm-1720	143	4	cd45	ORG
ajlm-1720	143	5	cd81	ORG
ajlm-1720	144	1	cd58	PRODUCT
ajlm-1720	144	2	haematogones)31	GPE
ajlm-1720	145	1	cd123	ORG
ajlm-1720	146	1	10c	CARDINAL
ajlm-1720	146	2	cd19	PRODUCT
ajlm-1720	146	3	cd19	ORG
ajlm-1720	146	4	cd10	PERSON
ajlm-1720	147	1	10c	CARDINAL
ajlm-1720	147	2	10	CARDINAL
ajlm-1720	150	1	cd22	ORG
ajlm-1720	150	2	cd123	ORG
ajlm-1720	150	3	alb	ORG
ajlm-1720	151	1	cd22-apc	ORG
ajlm-1720	151	2	alb	ORG
ajlm-1720	151	3	cd22	ORG
ajlm-1720	151	4	anti-cd22	NORP
ajlm-1720	152	1	second	ORDINAL
ajlm-1720	152	2	2	CARDINAL
ajlm-1720	153	1	cd5	PERSON
ajlm-1720	153	2	cd19	PRODUCT
ajlm-1720	153	3	cd20	PRODUCT
ajlm-1720	153	4	cd45	FAC
ajlm-1720	153	5	10c	CARDINAL
ajlm-1720	153	6	100%	PERCENT
ajlm-1720	153	7	20/20	CARDINAL
ajlm-1720	154	1	clb panel	ORG
ajlm-1720	154	2	cd81, ror1	ORG
ajlm-1720	154	3	cd43	ORG
ajlm-1720	155	1	second	ORDINAL
ajlm-1720	155	2	cd19/cd5	ORG
ajlm-1720	156	1	cd81	ORG
ajlm-1720	156	2	cd20	PRODUCT
ajlm-1720	156	3	cll	ORG
ajlm-1720	156	4	cll	ORG
ajlm-1720	156	5	cd19/cd10	ORG
ajlm-1720	156	6	cd43	ORG
ajlm-1720	156	7	clb panel	ORG
ajlm-1720	157	1	clb panel	ORG
ajlm-1720	157	2	cd38	PRODUCT
ajlm-1720	158	1	alb	ORG
ajlm-1720	159	1	clb panel	ORG
ajlm-1720	159	2	cll	ORG
ajlm-1720	159	3	cll	ORG
ajlm-1720	159	4	cd19/cd5	ORG
ajlm-1720	159	5	cd38	PRODUCT
ajlm-1720	159	6	cd45	PRODUCT
ajlm-1720	159	7	cd19	PRODUCT
ajlm-1720	159	8	cd56	PERSON
ajlm-1720	159	9	facscalibur/pag analysis	ORG
ajlm-1720	159	10	100%	PERCENT
ajlm-1720	159	11	17/17	CARDINAL
ajlm-1720	160	1	cd27	PRODUCT
ajlm-1720	161	1	cd117	ORG
ajlm-1720	162	1	one	CARDINAL
ajlm-1720	162	2	cd117-ecd	ORG
ajlm-1720	163	1	firstly	ORDINAL
ajlm-1720	164	1	secondly	ORDINAL
ajlm-1720	164	2	bc	ORG
ajlm-1720	165	1	setups23	PERSON
ajlm-1720	165	2	10c	CARDINAL
ajlm-1720	166	1	bc	ORG
ajlm-1720	166	2	duraclone alb	PERSON
ajlm-1720	166	3	second	ORDINAL
ajlm-1720	166	4	first	ORDINAL
ajlm-1720	166	5	10c	CARDINAL
ajlm-1720	167	1	cd81	ORG
ajlm-1720	167	2	cd43	PERSON
ajlm-1720	167	3	cll	ORG
ajlm-1720	168	1	second	ORDINAL
ajlm-1720	169	1	cd27	ORG
ajlm-1720	169	2	cd56	PERSON
ajlm-1720	169	3	cd81	ORG
ajlm-1720	169	4	cd200	GPE
ajlm-1720	169	5	cd19	PRODUCT
ajlm-1720	169	6	cd38	PRODUCT
ajlm-1720	175	1	d.l.	GPE
ajlm-1720	175	2	merriam machaba	PERSON
ajlm-1720	175	3	charlotte	GPE
ajlm-1720	175	4	johannesburg	GPE
ajlm-1720	178	1	d.l.	PERSON
ajlm-1720	181	1	l.s.	GPE
ajlm-1720	182	1	m.p.	GPE
ajlm-1720	185	1	l.s.	PERSON
ajlm-1720	185	2	first	ORDINAL
ajlm-1720	192	1	borowitz mj	PERSON
ajlm-1720	192	2	wood bl	PERSON
ajlm-1720	192	3	devidas m	PERSON
ajlm-1720	193	1	aall0232	PRODUCT
ajlm-1720	195	1	2015;126(8):964–971	DATE
ajlm-1720	195	2	mejstrikova e	ORG
ajlm-1720	197	1	2017;129(3):347–357	CARDINAL
ajlm-1720	197	2	https://doi.org/10.1182/blood-2016-07-726307 van dongen jj	PRODUCT
ajlm-1720	197	3	lhermitte l	ORG
ajlm-1720	199	1	2012;26(9):1908–1975	CARDINAL
ajlm-1720	200	1	kalina	LOC
ajlm-1720	200	2	van der velden vh	PERSON
ajlm-1720	204	1	8	CARDINAL
ajlm-1720	204	2	switzerland	GPE
ajlm-1720	207	1	https://doi.org/10.1016/j.jim.2017.07.013 kalina t	PERSON
ajlm-1720	208	1	j immunol	PERSON
ajlm-1720	209	1	2019;475:112520	CARDINAL
ajlm-1720	210	1	https://doi.org/10.1016/j.jim.2018.09.008 davis bh	PERSON
ajlm-1720	210	2	holden jt	PERSON
ajlm-1720	210	3	bene mc	PERSON
ajlm-1720	210	4	2006	DATE
ajlm-1720	211	1	cytometry b clin	ORG
ajlm-1720	211	2	cytom	GPE
ajlm-1720	212	1	2007;72	CARDINAL
ajlm-1720	213	1	hedley bd	PERSON
ajlm-1720	213	2	cheng g	PERSON
ajlm-1720	213	3	luider j	PERSON
ajlm-1720	215	1	cytom	GPE
ajlm-1720	216	1	2018;94(5):707–713	CARDINAL
ajlm-1720	216	2	hedley bd	PERSON
ajlm-1720	216	3	cheng g	PERSON
ajlm-1720	216	4	keeney m	PERSON
ajlm-1720	217	1	10c	CARDINAL
ajlm-1720	218	1	cytom.	DATE
ajlm-1720	219	1	2020	DATE
ajlm-1720	220	1	lst	ORG
ajlm-1720	223	1	hedley bd	PERSON
ajlm-1720	223	2	keeney m	PERSON
ajlm-1720	223	3	chin-yee i.	PERSON
ajlm-1720	224	1	cytom	GPE
ajlm-1720	225	1	2015;88(6):361–370	CARDINAL
ajlm-1720	226	1	https://doi.org/10.1002/cyto.b.21251 van der velden vhj,	PERSON
ajlm-1720	226	2	perez-andres	PERSON
ajlm-1720	228	1	2019;475:112287	CARDINAL
ajlm-1720	229	1	https://doi.org/10.1016/j.jim.2017.03.011 correia rp	PERSON
ajlm-1720	229	2	rajab	PERSON
ajlm-1720	230	1	ten	CARDINAL
ajlm-1720	232	1	2018;40(2):136–143	CARDINAL
ajlm-1720	232	2	loosveld m. detection	PERSON
ajlm-1720	232	3	eight	CARDINAL
ajlm-1720	233	1	cytom.	DATE
ajlm-1720	234	1	2019;96(2):158–163	CARDINAL
ajlm-1720	234	2	https://doi.org/10.1002/cyto.b.21766	ORG
ajlm-1720	235	1	de sousa f	PERSON
ajlm-1720	235	2	eight	CARDINAL
ajlm-1720	236	1	cytom	GPE
ajlm-1720	237	1	2020;98(6):529–535	CARDINAL
ajlm-1720	237	2	pretorius m	ORG
ajlm-1720	237	3	swart l	PERSON
ajlm-1720	237	4	lawrie d. evaluation	PERSON
ajlm-1720	237	5	bc	ORG
ajlm-1720	237	6	10c	CARDINAL
ajlm-1720	237	7	johannesburg	GPE
ajlm-1720	238	1	afr j	PERSON
ajlm-1720	239	1	2022;11(1):a1458	CARDINAL
ajlm-1720	239	2	rawstron ac	PERSON
ajlm-1720	239	3	fazi c	ORG
ajlm-1720	240	1	european	NORP
ajlm-1720	240	2	cll study	ORG
ajlm-1720	242	1	2016;30(4):929–936	CARDINAL
ajlm-1720	243	1	https://doi.org/10.1038/leu.2015.313 rawstron ac	PERSON
ajlm-1720	243	2	kreuzer ka	PERSON
ajlm-1720	243	3	soosapilla	PERSON
ajlm-1720	243	4	european	NORP
ajlm-1720	243	5	cll	ORG
ajlm-1720	243	6	eric) & european	ORG
ajlm-1720	244	1	cytom.	DATE
ajlm-1720	246	1	montero ja, gao q	PERSON
ajlm-1720	246	2	10	CARDINAL
ajlm-1720	246	3	8	CARDINAL
ajlm-1720	246	4	2	CARDINAL
ajlm-1720	248	1	2017;1(12):728–732	CARDINAL
ajlm-1720	249	1	bossuyt	PERSON
ajlm-1720	249	2	reitsma jb	PERSON
ajlm-1720	249	3	bruns de	ORG
ajlm-1720	251	1	clin chem	ORG
ajlm-1720	253	1	united kingdom	GPE
ajlm-1720	253	2	u.k. neqas) u. leukaemia immunophenotyping part	ORG
ajlm-1720	253	3	1	CARDINAL
ajlm-1720	253	4	2	CARDINAL
ajlm-1720	255	1	2021	CARDINAL
ajlm-1720	256	1	http://www.ukneqasli.co.uk/eqa-pt-programmes/flow-cytometry-programmes/leukaemia-immunophenotyping-part-1-accredited/ wang	PERSON
ajlm-1720	256	2	lin	PERSON
ajlm-1720	257	1	cytom	GPE
ajlm-1720	258	1	2019;96(5):338–350	CARDINAL
ajlm-1720	259	1	coulter sa	PERSON
ajlm-1720	260	1	2021	CARDINAL
ajlm-1720	262	1	2021	CARDINAL
ajlm-1720	263	1	campo e	PERSON
ajlm-1720	263	2	harris nl	PERSON
ajlm-1720	263	3	jaffe es	PERSON
ajlm-1720	264	1	geneva	PERSON
ajlm-1720	264	2	2017	CARDINAL
ajlm-1720	264	3	glencross dk	PERSON
ajlm-1720	265	1	plos one	PERSON
ajlm-1720	266	1	2014;9(12):e114727	CARDINAL
ajlm-1720	267	1	https://doi.org/10.1371/journal.pone.0114727 glencross dk	PERSON
ajlm-1720	267	2	janossy g	PERSON
ajlm-1720	268	1	south african	NORP
ajlm-1720	269	1	cytom	GPE
ajlm-1720	270	1	2008;74	CARDINAL
ajlm-1720	270	2	1	CARDINAL
ajlm-1720	271	1	glencross dk	PERSON
ajlm-1720	271	2	south africa	GPE
ajlm-1720	272	1	plos one.	ORG
ajlm-1720	273	1	2017;12(11):e0187456	CARDINAL
ajlm-1720	275	1	8	CARDINAL
ajlm-1720	278	1	-montero	PERSON
ajlm-1720	279	1	cytom	GPE
ajlm-1720	280	1	2016;90(1):61–72	CARDINAL
ajlm-1720	281	1	https://doi.org/10.1002/cyto.b.21265 chen f	PERSON
ajlm-1720	281	2	hu y	PERSON
ajlm-1720	281	3	wang x	PERSON
ajlm-1720	281	4	fu s	PERSON
ajlm-1720	281	5	liu z	PERSON
ajlm-1720	281	6	zhang j. expression	PERSON
ajlm-1720	281	7	cd81	ORG
ajlm-1720	281	8	cd117	ORG
ajlm-1720	283	1	2018;7(12):5920–5927	TIME
ajlm-1720	284	1	harris mh	PERSON
ajlm-1720	284	2	silverman lb	PERSON
ajlm-1720	284	3	weinberg ok	PERSON
ajlm-1720	284	4	cd81	ORG
ajlm-1720	284	5	cd58	ORG
ajlm-1720	286	1	2018;40(3):343–351	CARDINAL
ajlm-1720	286	2	zeidan ma	PERSON
ajlm-1720	286	3	kamal	PERSON
ajlm-1720	286	4	el shabrawy da	PERSON
ajlm-1720	286	5	sattar rh	PERSON
ajlm-1720	286	6	cd34/cd123	ORG
ajlm-1720	288	1	2016;59:113–118.	CARDINAL
ajlm-1720	289	1	broome	PERSON
ajlm-1720	289	2	wang hy	PERSON
ajlm-1720	289	3	meyer lm	PERSON
ajlm-1720	289	4	kipps	PERSON
ajlm-1720	292	1	2011;35(10):1390–1394	CARDINAL
ajlm-1720	293	1	https://doi.org/10.1016/j.leukres.2011.06.021 kohnke t	PERSON
ajlm-1720	293	2	vl	ORG
ajlm-1720	294	1	cll	ORG
ajlm-1720	294	2	five	CARDINAL
ajlm-1720	295	1	j haematol	PERSON
ajlm-1720	296	1	2017;179(3):480–487	PERSON
ajlm-1720	297	1	https://doi.org/10.1111/bjh.14901 mora	PERSON
ajlm-1720	299	1	cytom	GPE
ajlm-1720	300	1	2019;96(2):143–148	CARDINAL